×

Park YK, Kim HC, Kim BW, Xu W, Lee HW, Wang HJ. Auxiliary partial orthotopic liver transplantation as a treatment for hemophilia A: A case report. Transplantation Proceeding 2015;47:161-164.
Kim J, HeoY, Lee JCJ, Baek S, Kim Y, Moon J, Youn SH, Wang HJ, Huh Y, Jung K. Effective transport for trauma patients under current circumstances in Korea: A single institution analysis of treatment outcomes for trauma patients transported via the domestic 119 service. J Korean Med Sci 2015;30:336-342.
Cho HJ, Kim SS, Ahn SJ, Park SY, Park JH, Kim JK, Wang HJ, Cheong JY, Cho SW. Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related HCC who underwent curative treatment. Cytokine 2015;73:245-252.
Jung K, Kim Y, Heo Y, Lee JCJ, Youn SH, Moon J, Kim J, Kim TY, Kim BW, Wang HJ. Management of severe blunt liver injuries by applying the damage control strategies with packing-oriented surgery: Experiences at a single institution in Korea. Hepatogastroenterology 2015;62:410-416.
Cho HJ, Kim JK, Nam JS, Wang HJ, Lee JH, Kim BW, Kim SS, Noh CK, Shin SJ, Lee KM, Cho SW, Cheong JY. High circulating microRNA-122 exppression is a poor prognostic marker in patients with hepatitis B virus-related HCC who undergo radiofrequency ablation. Clinical Biochemistry 2015;48:1073-1078
Lee JH, Lee YK, Lim JJ, Byun HO, Park I, Kim KH, Xu WG, Wang HJ, Yoon G. Mitochindrial respiratory dysfunction induces claudin-1 expression via reactive oxygen species-mediated heat Shock factor 1 activation, leading to hepatoma cell invasiveness. J Biol Chem 2015;290(35):21421-21431.
Kwon JH, Ahn KS, Moon YH, Park JY, Wang HJ, Choi KY, Kim G. Joh JW, Lee KG, Kang KJ. AROS is a significant biomarker for tumor aggressiveness in non-cirrhotic HCC. J Korean Med Sci 2015;30:1253-1259.
Lee N, Kwon JH, Kim YB, Kim SH, Park SJ, Xu W, Jung HY, Kim KT, Wang HJ, Choi KY. Vaccinia-related kinase 1 promotes HCC by controlling the levels of cell cycle regulators associated with G1/S transition. Oncotarget 2015;6(30):30130-30148.
Lee YK, Jee BA, Kwon SM, Yoon YS, Xu WG, Wang HJ, Wang XW, Thorgeirsson SS, Lee JS, Woo HG, Yoon G. Identification of a mitochondrial defect gene signature reveals NUPR1 as a key regulator of liver cancer progression. Hepatology 2015;62:1174-1189.
Sim J, Lee J, Lee JKJ, Heo Y, Wang HJ, Jung K. Risk factors for mortality of severe trauma based on 3 years’ data at a single Korean institution. Ann Surg Treat Res 2015;89(4): 215-219.
Jeon JY, Wang HJ, Ock SY, Xu W, Lee JD, Lee JH, Kim HJ, Kim DJ, Lee KW, Han SJ. Newly developed sarcopenia as a prognostic factor for survival in patients who underwent liver transplantation. PLoS ONE 2015;10(11):e0143966
Kim T, Kim BW, Wang HJ, Lee HY, Won JH, Kim J, Hu XG, Sim J, Bang JB, Kim YB. Quantitative assessment of the portal pressure for the liver surgery using serological tests. Ann Surg 2016;264(2):330-338.
Hu XG, Hong SY, Kim BW, Xu W, Mao W, Wang HJ. Surgical Treatment for Hepatocellular Carcinoma with Bile Duct Invasion. Ann Surg Treat Res.2016;90(3):139-146
Cho HJ, Kim SS, Wang HJ, Kim BW, Cho H, Jung J, Cho SS, Kim JK, Lee JH, Kim YB, Yang MJ, Yoo BM, Lee KJ, Cho SW, Chung JY. Detection of novel genomic markers for predicting prognosis in HCC patients by integrative analysis of copy number aberrations and gene expression profiles: Results from a long-term follow-up. DNA and Cell Biology 2016;35(2):71-80.
Hu XG, Mao W, Park YK, Xu WG, Kim BW, Wang HJ. Blood neutrophil-to-lymphocyte ratio predicts tumor recurrence in patients with HCC within Milan criteria after hepatectomy. Yonsei Medical Journal 2016; 57(5):1115-1123.
Bang JB, Kim BW, Kim YB, Wang HJ, Lee HY, Sim JH, Kim T, Lee KL, Hu XG, Mao W. Risk factor for ischemic-type biliary lesion after ABO-incompatible living donor liver transplantation. World J Gastroenterology 2016;22:6925-6935.
Park YK, Song SK, Kim BW, Park SK, Lee JI, Lim SS, Wang HJ. Conditional survival analysis demonstrates that recurrence risk of surgically treated hepatocellular carcinoma. J Gastrointest Surg 2017;21:1237-1244
Choi JH, Kim MJ, Park YK, Im JY, Kwon SM, Kim HC, Woo HG, Wang HJ. Mutations acquired by HCC recurrence give rise to an aggressive phenotype. Oncotarget 2017;8(14):22903-22916.
Kaibori M, Kon M, Kityawaki T, Wang HJ et al. Comparison of anatomic and nonanatomic hepatic resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2017;24:616-626
Park YK, Song SK, Kim BW, Park SK, Chung CW, Wang HJ. Prognostic significance of microvascular invasion in tumor stage for hepatocellular carcinoma. World J Surg Oncol. 2017;15:225-35
Choi HJ, Kim DG, Kim SI, Wang HJ, Joh JW, Suh KS, Kim SH. A multicenter phase III study to uate the efficacy and safty of hepabulin, a new hepatitis B immunoglobulin, in liver transplantation recipients with hepatitis B. Ann Transplantation 2017;22:740-748
Cho HJ, Kim SS, Nam JS, Wang HJ et al. Low level of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment. Clinics and Research in Hepatology and Gastroenterology 2017;41:181-189
Hong SY, Kim BW, Wang HJ, Kim IG, Hu XG. Hanging hepatoatrial anastomosis in deceased-donor liver transplantation for Budd-Chiari syndrome with extensive vena cava obliteration: A case report. Transpl Proceeding 2017;49:2395-2398
Yoon S, Lee EJ, Chung T, Wang HJ et al. Recapitulation of pharmacogenomics data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer. Oncogene 2018 Aug;37(32):4443-4454
Hwang S, Joh JW, Wang HJ, et al. Prognostic prediction models for resection of large hepatocellular carcinoma: A Korean multicenter study. W J Surg 2018; 42(8):2579-2591
Hu XG, Kim IG, Wang HJ et al. Reuse of living-donor liver graft in second recipient with long-term survival. Transpl Proceeding 2018;50:3984-3987
Hong SY, Hu XG, Lee HY, Won JH, Kim JW, Shen XY, Wang HJ, Kim BW. Long-term analysis of biliary complications after duct-to-duct biliary reconstruction in living donor liver transplantations. Liver transplantation 2018;24:1050-1061
Lee JH, Kim BH, Kim HJ, Kim BW, Wang HJ, Kim JK. High spatial resolution navigated 3D T1-weighted hepatobiliary MR cholangiography using Gd-EOB-DTPA for uation of biliary anatomy in living liver donors. Abdominal Radiology 2018;43:1703-1712
Noh CK, Wang HJ, Kim CM et al. EpCAM as a predictive marker of tumor recurrence and survival in patients who underwent surgical resection for hepatocellular carcinoma. Anticancer Res. 2018;38(7):4101-410
Park JI, Kim KH, Kim HJ, Cherqui D, Wang HJ, et al. Highlights of the third expert forum of Asia-Pacific laparoscopic hepatectomy; Endoscopic and Laparoscopic Surgeons of Asia (ELSA) visionarry summit 2017. Ann Hepatobiliary pancreat Surg 2018;22:1-10
Kim IG, Hu XG, Wang HJ, Kim BW, Hong SY, Shen XY. The 7th/8th American Joint Committee on Cancer and the modified Union for International Cancer Control Staging System for hepatocellular carcinoma. Yonsei Medical Journal 2019;60(2):140-147.
Yang HD, Kim HS, Kim SY, Na MJ, Yang G, Eun JW, Wang HJ, Cheong JY, Park WS, Nam SW. HDAC6 suppress Let-7i-5p to elicit TSP1/CD47-mediated anti-tumorigenesis and phagocytosis of hepatocellular carcinoma. Hepatology 2019;70(4):1262-1279.
Shen XY, Wang HJ, Kim BW, Hong SY, Kim MN, Hu XG. Can we delineate preoperatively the right and ventral margins of caudate lobe of the liver? ASTR 2019;97(3):124-129
Kim JD, Cho EJ, Ahn C, Park SK, Choi JY, Lee HJ, Kim DY, Choi MS, Wang HJ, Kim YJ et al. A model to predict 1-month risk of transplant or death in hepatitis A-related acute liver failure. Hepatology 2019;70(2):621-629
Shen XY, Hu XG, Kim YB, Kim MN, Hong SY, Kim BW, Wang HJ. Molecular classification of hepatocellular adenoma: a single center experience. Ann Hepatobiliary pancreat Surg 2019;23:109-114.
Chang Min Kim, Shin Hwang, Bhumsuk Keam, Yun Suk Yu, Ji Hoon Kim, Dong-Sik Kim, Si Hyun Bae, Gun-Do Kim, Jong Kyu Lee, Yong Bae Seo, Soon Woo Nam, Koo Jeong Kang, Luigi Buonaguro, Jin Young Park, Yun Soo Kim, Hee Jung Wang. Gene Signature for Sorafenib Susceptibility in Hepatocellular Carcinoma: different approach of predictive biomarker. Liver Cancer 2020;9(2):182-192 (DOI: 10.1159/000504548)
Xu-Guang Hu, Xue-Yin Shen, Jin-Niang Nan, In-Gyu Kim, Joon-Kee Yoon, Sung Yeon Hong, Mina Kim, Bong-Wan Kim, Hee-Jung Wang. 18F-FDG PET/CT as an independent predictor for patients with HCC combined with major portal vein tumor thrombus. ASTR 2020;99(1):8-17
Kim DS, Kim BW, Hatano E, Hwang S, Hasegawa K, Kudo A, Ariizumi S, Kaibori M, Wang HJ, Yamamoto M, et al. Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombi. Ann Surg 2020:271(5):913-921
Yamamoto M, Yoshida M,…, Wang HJ, Adam R, Oh DY, Takada T. Clinical Guidelines for the management of liver metastases from extrahepatic primary cancers 2021. J Hepatobiliary Pancreat Sci 28(1):1-25
Mao W, Jiang X, Cao Y, Xiong S, Huang Y, Jiao L, Wang HJ. A practical study of the hepatic vascular system anatomy of the caudate lobe Quant Imaging Med Surg 2021;11(4):1313-1321
Kwon SM, Lee YK, Min S, Woo HG, Wang HJ, Yoon G. Mitoribosome defect in HCC promotes aggressive phenotype with suppressed immune reaction. iScience 23, 101247, June 26, 2020
Lee YK, Kwon SM, Lee EB, Kim KH, Min S, Hong SM, Wang HJ, Lee DM, Choi KS, Park TJ, Yoon G. Mitochondrial respiratory defect enhances hepatoma cell invasiveness via STAT3/NFE2L1/STX12 axis. Cancer 2020, 12(9):2632(Accepted: 14 September 2020).